China's demand for Autoimmune Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1998, 2003 and 2008) and long-term forecasts throught 2013 and 2018 are presented. Major producers in China are profiled.

I. INTRODUCTION
Report Scope and Methodology
Executive Summary

II. BUSINESS ENVIRONMENT
Economic Outlook
Key Economic Indicators
Industrial Output
Population and Labor
Foreign Investment
Foreign Trade
Financial and Tax Regulations
Banking System and Regulations
Foreign Exchange
Taxes, Tariff and Custom Duties

III. AUTOIMMUNE DRUGS INDUSTRY ASSESSMENTS
Autoimmune Drugs Industry Structure
Market Size
Market Growth Drivers
Autoimmune Drugs Industry Sales Volumes
Major Producer Facility Locations and Sales Volumes
Market Share of Key Producers
Labor Cost
Potential Entrants
Major Distributors
Major Foreign Investments
Technology Development

IV. AUTOIMMUNE DRUGS PRODUCTION AND DEMAND
Overview
Sales Volumes of Autoimmune Drugs by Region in 2008
Autoimmune Drugs Sales Volumes
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
Corticosteroids
Immunosuppressant Drugs
Other Autoimmune Drugs
Autoimmune Drugs Imports and Exports
Autoimmune Drugs Imports
Autoimmune Drugs Exports
Pricing Trends

V. AUTOIMMUNE DRUGS MARKET OUTLOOK
Autoimmune Drugs Markets Outlook Overview
Government Regulation
Health Care Insurance Industry Overview
Consumer Spending Trends
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Physicians and Physician Visits

VI. MARKET ENTRY CHANNELS
China Market Entry Overview
China’s Distribution System
Plastic Distribution Channels
Transportation and Freight Infrastructure
Communications
China’s Market Entry
Export to China
Indirect export
Direct Export
License and Contract Manufacture
Assembling in China
Contract Manufacturing
Trade Permit
Investment
Equity Joint Venture
Contractual Joint Venture
Wholly Foreign-Owned Enterprise

VII. AUTOIMMUNE DRUGS PRODUCER DIRECTORY
Major Plastics Producer Profiles
Distributors and Trading Companies
Associations and Research Institutes
Major End-Users

LIST OF TABLES
I. INTRODUCTION
Economic Outlook Summary
Autoimmune Drugs Sales Volumes
II. BUSINESS ENVIRONMENT
Key Economic Indicators
Industrial Output
Population and Labor Force Trends
Foreign Investment and Loans
Foreign Trade
Key Commodity Exports from China
China’s Exports to its Leading Trade Partners
Key Commodity Imports into China
China’s Imports from Its Leading Trade Partners
III. AUTOIMMUNE DRUGS INDUSTRY ASSESSMENTS
Autoimmune Drugs Industry Sales Volumes
Major Producer Facility Locations
Major Autoimmune Drugs Producer Sales Volumes
Market Share of Key Producers
Major Foreign Investments in China
IV. AUTOIMMUNE DRUGS PRODUCTION AND DEMAND
Autoimmune Drugs Sales Volumes
Sales Volumes of Autoimmune Drugs by Region in 2008
NSAIDs Sales Volumes
Corticosteroids Sales Volumes
Immunosuppressants Sales Volumes
Other Autoimmune Drugs Sales Volumes
China Autoimmune Drugs Imports and Exports
V. AUTOIMMUNE DRUGS MARKET OUTLOOK
Total Autoimmune Drugs Sales Volumes by Market
Consumer Spending Trends
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Physicians and Physician Visits

LIST OF CHARTS
I. INTRODUCTION
China’s Autoimmune Drugs Sales Volumes
II. BUSINESS ENVIRONMENT
China’s GDP and Growth Rate
Industrial Output by Ownership
China’s Imports and Exports
III. AUTOIMMUNE DRUGS INDUSTRY ASSESSMENTS
Autoimmune Drugs Sales Volumes in China
Autoimmune Drugs Sales Volumes
IV. AUTOIMMUNE DRUGS PRODUCTION AND DEMAND
Total Autoimmune Drugs Sales Volumes
Total Autoimmune Drugs Imports and Exports
V. AUTOIMMUNE DRUGS MARKETS OUTLOOK
Autoimmune Drugs Sales Volume by Market in 2008
VI. MARKETING STRATEGIES
China’s Distribution Channel